Michele Maio

17PUBLICATIONS
153CO-AUTHORS
Gene and molecular therapyMolecular targetsTumour immunologyMedical mycologyMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Aug 12, 2026
COMBI-I: Long-Term Overall Survival With Spartalizumab Plus Dabrafenib and Trametinib in BRAF V600-Mutant Advanced Melanoma.

|Aug 11, 2026
Neoadjuvant Intralesional Daromun (L19IL2/L19TNF) in Resectable Locally Advanced Melanoma: An Update on the Efficacy and Safety Results of the PIVOTAL Phase III Trial.

|Aug 07, 2026
Transposable elements and homotypic niches drive immune dynamics and resistance in melanoma epigenetic-based immunotherapy.

|May 07, 2026
Circulating EV-microRNAs are dynamic biomarkers of resistance to therapeutic immunomodulation in metastatic melanoma.

|Nov 24, 2025
Transposable Elements and Homotypic Niches Drive Immune Dynamics and Resistance in Melanoma Epigenetic-based immunotherapy.

Erika Ciervo, Francesco Ceccarelli, Anna Maria Di Giacomo

|Jul 03, 2025
Unraveling Relatlimab-Specific Biology Using Biomarker Analyses in Patients with Advanced Melanoma in RELATIVITY-047.

Evan J Lipson, Sonia Dolfi, Hao Tang

Pageof 3

Frequent Collaborators

6 joint publications

Paolo Antonio Ascierto

4 joint publications

Céleste Lebbé

4 joint publications

Francesca Pia Caruso

4 joint publications

Dirk Schadendorf